Long-Term Treatment Strategies of Pediatric Multiple Sclerosis, Including the use of Disease Modifying Therapies
Multiple sclerosis (MS) presenting in the pediatric years can lead to landmark disability levels younger in life than adult onset MS and so therefore early and effective treatment remains paramount for long-term outcomes. The goals of MS therapeutics in adults have widened to address multiple mechan...
Saved in:
Main Author: | Mary Rensel (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2019-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Review Of The Safety, Efficacy And Tolerability Of Fingolimod In The Treatment Of Pediatric Patients With Relapsing-Remitting Forms Of Multiple Sclerosis (RRMS)
by: Feng J, et al.
Published: (2019) -
Personalized Use of Disease-Modifying Therapies in Multiple Sclerosis
by: Chi-Yan Lee, et al.
Published: (2024) -
Disease Modifying Therapy in Multiple Sclerosis: Evaluation of Patients Satisfaction in Iranian Multiple Sclerosis Population
by: Negar Molazadeh, et al.
Published: (2023) -
Disease modifying therapies in multiple sclerosis: cost-effectiveness systematic review
by: Cristian Eduardo Navarro, et al.
Published: (2020) -
Emerging therapies for treatment of multiple sclerosis
by: John R Corboy, et al.
Published: (2010)